Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Lipids|June 18, 2014
Re-esterified palm oils, compared to native palm oil, do not alter fat absorption, postprandial lipemia or growth performance in broiler chicksE Vilarrasa, A Tres, L Bayés-García, et al.
Actas Dermo-Sifiliograficas|January 31, 2023
Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of ExpertsJ M Carrascosa, E Vilarrasa, I Belinchón, et al.
Actas Dermo-Sifiliograficas|December 10, 2025
Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and VenereologyL Puig, J M Carrascosa, R Rivera, et al.
Actas Dermo-Sifiliograficas|July 14, 2023
Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin DiseasesE Vilarrasa, J Nicolau, P de la Cueva, et al.
Actas Dermo-Sifiliograficas|November 2, 2023
[Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin DiseasesE Vilarrasa, J Nicolau, P de la Cueva, et al.
Actas Dermo-Sifiliograficas|March 22, 2026
Spanish Clinical Management Guideline for Hidradenitis Suppurativa. Part I: Pathogenesis, Diagnosis, and Disease StagingA Martorell Calatayud, F Alfageme Roldán, F J García-Martínez, et al.
Actas Dermo-Sifiliograficas|August 10, 2015
An Update on Hidradenitis Suppurativa (Part I): Epidemiology, Clinical Aspects, and Definition of Disease SeverityA Martorell, F J García-Martínez, D Jiménez-Gallo, et al.
Actas Dermo-Sifiliograficas|April 27, 2019
Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis SuppurativaS E Marrón, M Gómez-Barrera, L Tomás-Aragonés, et al.
Heliyon|October 20, 2023
Valorization of wipe wastes for the synthesis of microporous carbons and their application in CO<sub>2</sub> capture, gas separation and H<sub>2</sub>-storageJ A Cecilia, E Vilarrasa-García, D C S Azevedo, et al.
The British Journal of Dermatology|September 19, 2012
Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical settingR Navarro, E Vilarrasa, P Herranz, et al.
Pageof 6